Skip Navigation LinksHome > August 2011 - Volume 11 - Issue 4 > An evidence-based appraisal of the surrogate markers of effi...
Current Opinion in Allergy & Clinical Immunology:
doi: 10.1097/ACI.0b013e328348a7cd
Pharmacotherapy and evidence based medicine: Edited by David A. Khan and Enrico Compalati

An evidence-based appraisal of the surrogate markers of efficacy of allergen immunotherapy

Senna, Gianenrico; Calderon, Moises; Makatsori, Melina; Ridolo, Erminia; Passalacqua, Giovanni

Collapse Box


Purpose of review: The assessment of clinical efficacy of immunotherapy in patients with respiratory allergy is highly affected by variability and lack of validated outcome measures such as symptom and medication scores. At the same time, there is a need to identify reliable predictive surrogate markers or biomarkers that may correlate with real clinical endpoints and lead to individually tailored immunotherapy treatment.

Recent findings: In-vivo markers, such as early and late skin reaction as well as immunological parameters such as IgE levels, IgG subclasses, mucosal IgA, lymphocyte subsets, cytokines and local and systemic inflammatory markers, have been proposed as potential surrogate markers.

Summary: Given the poor reproducibility and surrogacy to clinical outcomes shown in various clinical trials, the decreased availability in daily practice and anticipated high costs, an ideal surrogate marker is still not available to allergists.

Copyright © 2011 Wolters Kluwer Health, Inc. All rights reserved.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.